HIKAL Executive and Leadership Team

Shankar Gopalakrishnan, the Chief Financial Officer at HIKAL, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer manages investor relations and ensures compliance with international accounting standards. This leadership role involves optimizing cost structures across the Mumbai headquarters and global manufacturing sites to support sustainable growth. By implementing robust risk management frameworks, Shankar Gopalakrishnan directly impacts the long-term profitability of the company. The Chief Financial Officer monitors cash flow efficiency and capital expenditure projects to align with the broader corporate vision. Through precise financial forecasting, the Chief Financial Officer secures the necessary resources for expanding the custom synthesis and contract manufacturing capabilities. Ultimately, the Chief Financial Officer maintains the fiscal integrity required to navigate the complex agrochemical and specialty chemical markets while delivering consistent value to shareholders and stakeholders.

Vimal Kulshrestha, the President- Specialty Chemical and Crop ProtectionDivision at HIKAL, directs the operational strategy for specialty chemical production and agrochemical manufacturing. Overseeing the technical development teams, the President- Specialty Chemical and Crop ProtectionDivision ensures that manufacturing processes meet the highest safety and quality benchmarks. This leadership role involves scaling production capacity to meet the demands of international clients seeking custom synthesis solutions. By driving innovation in chemical synthesis, Vimal Kulshrestha directly impacts the competitive positioning of the company within the global market. The President- Specialty Chemical and Crop ProtectionDivision coordinates with research departments to accelerate the commercialization of new chemical intermediates. Through efficient supply chain management, the President- Specialty Chemical and Crop ProtectionDivision optimizes the delivery of specialty chemicals to diverse industrial sectors. Ultimately, the President- Specialty Chemical and Crop ProtectionDivision fosters operational excellence to maintain the reputation of the company as a premier contract manufacturing partner.

Ravi Khadabadi, the President, Crop Protection & Specialty Chemicals at HIKAL, directs the market expansion and product development initiatives for the crop protection portfolio. Overseeing the commercial strategy, the President, Crop Protection & Specialty Chemicals ensures that the product offerings align with the evolving needs of the global agricultural sector. This leadership role involves managing key client relationships and identifying new opportunities for contract manufacturing partnerships. By analyzing market trends, Ravi Khadabadi directly impacts the revenue growth of the crop protection division. The President, Crop Protection & Specialty Chemicals collaborates with the technical teams to refine chemical formulations and improve product efficacy. Through strategic planning, the President, Crop Protection & Specialty Chemicals drives the adoption of sustainable chemical solutions across international markets. Ultimately, the President, Crop Protection & Specialty Chemicals secures the market share of the company by delivering high-performance agrochemical products that support modern farming requirements.

Manoj Mehrotra, the President, Pharmaceutical Business at HIKAL, directs the strategic growth and operational execution of the pharmaceutical manufacturing division. Overseeing the development of active pharmaceutical ingredients and intermediates, the President, Pharmaceutical Business ensures strict adherence to global regulatory standards. This leadership role involves managing complex manufacturing projects and coordinating with international pharmaceutical partners to provide reliable contract development services. By optimizing production workflows, Manoj Mehrotra directly impacts the efficiency and output quality of the pharmaceutical business. The President, Pharmaceutical Business works closely with the quality assurance teams to maintain compliance and safety across all manufacturing facilities. Through the implementation of advanced synthesis technologies, the President, Pharmaceutical Business enhances the capabilities of the company in the pharmaceutical sector. Ultimately, the President, Pharmaceutical Business drives the expansion of the pharmaceutical portfolio to meet the critical needs of the global healthcare industry.